Indication

Wiskott-Aldrich syndrome

Wiskott-Aldrich syndrome is a rare, X-linked primary immunodeficiency disorder primarily affecting males, caused by hemizygous pathogenic variants in the *WAS* gene. Read more about Wiskott-Aldrich syndrome

46 drugs 18 manufacturers

Advertisement

Drugs that treat it

Common Wiskott-Aldrich syndrome therapies.

Showing 1–9 of 46 drugs

Filter & compare in the drug finder →Opens the drug finder with Wiskott-Aldrich syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Wiskott-Aldrich syndrome.

Wiskott-Aldrich syndrome is a rare, X-linked primary immunodeficiency disorder primarily affecting males, caused by hemizygous pathogenic variants in the *WAS* gene.

This gene defect leads to a deficiency or absence of the Wiskott-Aldrich syndrome protein (WASP), an essential regulator of actin cytoskeleton remodeling in hematopoietic lineages.

Pathophysiologically, this impairment disrupts leukocyte activation and signaling, compromises platelet morphogenesis, and leads to accelerated platelet clearance.

Clinically, the condition is classically defined by the triad of microthrombocytopenia with abnormally small platelets, recurrent pyogenic and viral infections due to combined humoral and cellular immunodeficiency, and atopic eczema, alongside heightened lifetime risks for autoimmune cytopenias and hematologic malignancies.

Personalize your experience

Follow Wiskott-Aldrich syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it